메뉴 건너뛰기




Volumn 46, Issue 3, 2014, Pages 431-434

New guidelines for metabolic targets in diabetes: Clinician's opinion does matter

Author keywords

Diabetes mellitus; Guidelines; Metabolic targets

Indexed keywords

ATORVASTATIN; CHOLESTEROL; HEMOGLOBIN A1C; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN;

EID: 84904545509     PISSN: 1355008X     EISSN: 15590100     Source Type: Journal    
DOI: 10.1007/s12020-014-0205-2     Document Type: Article
Times cited : (6)

References (18)
  • 1
    • 0016264378 scopus 로고
    • Judgment under uncertainty: Heuristics and biases
    • A. Tversky, D. Kahneman, Judgment under uncertainty: heuristics and biases. Science 185, 1124-1131 (1974)
    • (1974) Science , vol.185 , pp. 1124-1131
    • Tversky, A.1    Kahneman, D.2
  • 2
    • 0028884793 scopus 로고
    • The need for evidence-based medicine
    • D.L. Sackett, W.M. Rosenberg, The need for evidence-based medicine. J. R. Soc. Med. 88, 620-624 (1995)
    • (1995) J. R. Soc. Med. , vol.88 , pp. 620-624
    • Sackett, D.L.1    Rosenberg, W.M.2
  • 3
    • 0035286796 scopus 로고    scopus 로고
    • The end of the beginning for genomic medicine
    • D. Bailey, E. Zanders, P. Dean, The end of the beginning for genomic medicine. Nat. Biotechnol. 19, 207-209 (2001)
    • (2001) Nat. Biotechnol. , vol.19 , pp. 207-209
    • Bailey, D.1    Zanders, E.2    Dean, P.3
  • 4
    • 84879393203 scopus 로고    scopus 로고
    • Personalized medicine versus guideline-based medicine
    • J.J. Goldberger, A.E. Buxton, Personalized medicine versus guideline-based medicine. J. Am. Med. Assoc. 309, 2559-2560 (2013)
    • (2013) J. Am. Med. Assoc. , vol.309 , pp. 2559-2560
    • Goldberger, J.J.1    Buxton, A.E.2
  • 5
    • 84885583673 scopus 로고    scopus 로고
    • Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes?
    • K. Esposito, A. Ceriello, D. Giugliano, Does personalized diabetology overcome clinical uncertainty and therapeutic inertia in type 2 diabetes? Endocrine 44, 343-345 (2013)
    • (2013) Endocrine , vol.44 , pp. 343-345
    • Esposito, K.1    Ceriello, A.2    Giugliano, D.3
  • 7
    • 84904577615 scopus 로고    scopus 로고
    • The AMD Annals 2010 Working Group. Accessed 15 Jan 2014
    • The AMD Annals 2010 Working Group. Quality indicators in diabetes care in Italy. (http://www.infodiabetes.it/files/ANNALIAMD/2010/ Annali%202010%20inglese.pdf page 48). Accessed 15 Jan 2014
    • Quality Indicators in Diabetes Care in Italy
  • 8
    • 84975856269 scopus 로고    scopus 로고
    • Economic costs of diabetes in the US in 2012
    • American Diabetes Association
    • American Diabetes Association, Economic costs of diabetes in the US in 2012. Diabetes Care 36, 1033-1046 (2013)
    • (2013) Diabetes Care , vol.36 , pp. 1033-1046
  • 9
    • 84882276623 scopus 로고    scopus 로고
    • Comprehensive diabetes management algorithm
    • American Association of Clinical Endocrinologists
    • American Association of Clinical Endocrinologists, Comprehensive diabetes management algorithm. Endocr. Pract. 19, 327-336 (2013)
    • (2013) Endocr. Pract. , vol.19 , pp. 327-336
  • 11
    • 84892649479 scopus 로고    scopus 로고
    • American Diabetes Association Position Statement, Standards of medical care in diabetes-2014
    • American Diabetes Association Position Statement, Standards of medical care in diabetes-2014. Diabetes Care 37(Suppl 1), S14-S80 (2014)
    • (2014) Diabetes Care , vol.37 , Issue.SUPPL. 1
  • 13
    • 84899585586 scopus 로고    scopus 로고
    • Are glycated serum proteins ready for prime time?
    • doi:10.1016/S2213-8587(14)70003-8
    • R.M. Cohen, W.H. Herman. Are glycated serum proteins ready for prime time? Lancet Diabetes Endocrinol (2014). doi:10.1016/S2213-8587(14)70003-8
    • (2014) Lancet Diabetes Endocrinol
    • Cohen, R.M.1    Herman, W.H.2
  • 16
    • 84893325766 scopus 로고    scopus 로고
    • More than a billion people taking statins? Potential implications of the new cardiovascular guidelines
    • doi:10.1001/jama.2013.284657
    • J.P. Ioannidis, More than a billion people taking statins? Potential implications of the new cardiovascular guidelines. J. Am. Med. Assoc. (2013). doi:10.1001/jama.2013.284657
    • (2013) J. Am. Med. Assoc.
    • Ioannidis, J.P.1
  • 17
    • 84893606587 scopus 로고    scopus 로고
    • Recommendations for treating hypertension. What are the right goals and purposes?
    • E.D. Peterson, J.M. Gaziano, P. Greenland, Recommendations for treating hypertension. What are the right goals and purposes? J. Am. Med. Assoc. 311(5), 474-476 (2014)
    • (2014) J. Am. Med. Assoc. , vol.311 , Issue.5 , pp. 474-476
    • Peterson, E.D.1    Gaziano, J.M.2    Greenland, P.3
  • 18
    • 79955040917 scopus 로고    scopus 로고
    • Clinical inertia as a clinical safeguard
    • D. Giugliano, K. Esposito, Clinical inertia as a clinical safeguard. J. Am. Med. Assoc. 305, 1591-1592 (2011)
    • (2011) J. Am. Med. Assoc. , vol.305 , pp. 1591-1592
    • Giugliano, D.1    Esposito, K.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.